Our team, made up of experienced PhD and graduate chemists, quality control personnel, QC analysts, and administrative staff is justifiably proud of the work it has done, and continues to do, for our clients.
Roy Valentine. BSc, PhD, CChemChief Executive Officer
Roy’s background includes employment at Ciba Geigy, Givauden and he helped to establish Wendstone Chemicals which was later acquired by Laporte, before setting up High Force Research together with Stuart Penny and Bob Redfern.
In his previous role as Research Director, Roy oversaw all of the non-GMP specific chemistry projects and managed a team of synthetic chemists made up of Team Leaders and Research and Process Development Chemists with BSC; PhD and Post-Doctoral experience.
Roy’s focus is now primarily on business strategy and planning, sales and marketing, finance, human resources, sourcing and regulatory compliance.
Stuart Penny. MRSC, CChem Operations Director
As Operations Director, Stuart introduced GMP operations to High Force Research and is currently responsible for overseeing development of new chemical entities through development to small scale GMP manufacture. Stuart is responsible for preparing all GMP proposals and manages a team of GMP trained Chemists and is the direct report for QA.
Before helping establish High Force Research he previously worked in the Fine Chemicals Industry where he gained many years experience as a Process Development Chemist in laboratory and pilot plant operations.
Zoe Hudson. BSc, MScHead of Quality Assurance
Zoe worked as a laboratory technician at GSK before joining High Force Research in 1996 where she initially started work as a technician in the synthetic development laboratories. She quickly became involved with the GMP aspects of High Force Research’s work and was fundamental in setting up the quality control department. Zoe later became the QC Manager of this department. Zoe’s synthetic and analytical knowledge has enabled her to become a key figure in the architecture of High Force Research’s quality system over the past 10 years, which she now manages.
Nicola Lembicz. BSc, PhDResearch Manager
Nicola joined High Force Research in 1996 after completing her PhD at Newcastle University with Prof Bernard Golding on ‘The design and synthesis of novel inhibitors of the DNA repair enzyme MGMT.’ She has successfully completed many research projects with High Force Research and has particular expertise in nucleoside and carbohydrate chemistries and in synthesising polymers / monomers for OLED / printed electronics applications. Nicola is responsible for all new and current research and development projects.
Barry Thompson. BSc, PhDDevelopment Manager
Barry joined High Force Research in 2002 after completing his PhD at Sunderland University, studying the multistep convergent synthesis of alnusoxide. His role at HFR is primarily focused on process development and the scale up of chemical processes to the kilogram scale, utilising the large scale reactors and equipment at High Force Research’s Bowburn and Wilton Centre laboratories. Expertise includes the development of API intermediates, electronic and inorganic compounds, plus polymers and nanoparticles.
Neil Sim. MChem, PhDResearch Team Leader
Neil joined High Force Research in the Autumn of 2014 following a highly successful PhD under the supervision of Prof. David Parker FRS at Durham University, where he developed novel imaging probes for glutamate receptors. Initially joining the chemical R&D team at Bowburn, Neil quickly became more involved in all new projects at High Force, and in 2016 was appointed to lead the team at High Force Research’s new Wilton laboratories. Neil’s role involves the management of all aspects of work at the Wilton site as well as facilitating new academic partnerships and collaborations. He has expertise in multistep chemical synthesis across a range of sectors, with particular focus on Molecular Imaging and Diagnostics.
Jennifer Wallis. MChem, MPhil, EngDBusiness Development Executive
Jennifer joined High Force Research in 2017 after completing her EngD in Biopharmaceutical Process Development at Newcastle University. The research project was in collaboration with HFR and the research group of Dr Lee J. Higham, and looked at the synthesis of fluorescent phosphines and phosphorus-containing compounds for use in medical imaging and catalysis.
Her role at HFR is in business development where she identifies new business opportunities, builds key customer relationships and helps to manage current customer projects.